After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, KNSA falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Kiniksa Pharmaceuticals International Plc is $2.67B. A total of 0.35 million shares were traded on the day, compared to an average of 684.94K shares.
In the most recent transaction, Tessari Eben sold 16,400 shares of KNSA for 36.46 per share on Sep 15 ’25. After the transaction, the CHIEF OPERATING OFFICER now owns 34,552 company shares. In a previous transaction on Sep 15 ’25, Tessari Eben bought 16,400 shares at 36.46 per share.
Among the insiders who sold shares, Tessari Eben disposed of 85,271 shares on Sep 04 ’25 at a per-share price of $35.52. This resulted in the CHIEF OPERATING OFFICER holding 44,452 shares of KNSA after the transaction. In another insider transaction, Tessari Eben sold 13,389 shares at $35.66 per share on Sep 05 ’25. Company shares held by the CHIEF OPERATING OFFICER now total 44,452.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, KNSA has a high of $37.34 and a low of $17.82.
As of this writing, KNSA has an earnings estimate of $0.37 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $0.56 per share and a lower estimate of $0.26. The company reported an EPS of -$0.18 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. KNSA’s latest balance sheet shows that the firm has $182.20M in Cash & Short Term Investments as of fiscal 2021. There were $6.05M in debt and $44.82M in liabilities at the time. Its Book Value Per Share was $6.69, while its Total Shareholder’s Equity was $185.04M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KNSA is Buy with a score of 5.00.
